Pages that link to "Q48622377"
Jump to navigation
Jump to search
The following pages link to Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. (Q48622377):
Displaying 50 items.
- Lithium: the pharmacodynamic actions of the amazing ion (Q22241779) (← links)
- Tau pathology in Alzheimer disease and other tauopathies (Q22252520) (← links)
- Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules (Q24302556) (← links)
- Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder (Q24626017) (← links)
- Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics (Q24685475) (← links)
- Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent (Q27621242) (← links)
- Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 (Q27641873) (← links)
- Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin (Q28137764) (← links)
- Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta (Q28208444) (← links)
- Mood stabilizers, glycogen synthase kinase-3beta and cell survival (Q28216404) (← links)
- Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder (Q28251880) (← links)
- beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment (Q28376637) (← links)
- Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition (Q28468536) (← links)
- Chronic lithium chloride administration to rats decreases brain protein level of epsilon (epsilon) subunit of eukaryotic initiation factor-2B (Q28564477) (← links)
- Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils (Q28570115) (← links)
- Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes (Q28578658) (← links)
- PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations (Q28587440) (← links)
- LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin (Q28757894) (← links)
- Zebrafish models of Tauopathy (Q28833507) (← links)
- The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling (Q29620489) (← links)
- Identification of targets of the Wnt pathway destruction complex in addition to beta-catenin (Q30438408) (← links)
- A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation (Q30487256) (← links)
- GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals (Q30619452) (← links)
- Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription (Q31462537) (← links)
- A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? (Q33284843) (← links)
- Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase (Q33298503) (← links)
- Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation (Q33300947) (← links)
- Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models (Q33552220) (← links)
- Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway (Q33553429) (← links)
- Recent developments in the drug treatment of Alzheimer's disease (Q33688768) (← links)
- Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? (Q33745706) (← links)
- Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice (Q33766526) (← links)
- Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo (Q33771431) (← links)
- Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons (Q33801220) (← links)
- Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats (Q33835741) (← links)
- Mechanisms of tau-induced neurodegeneration (Q33859830) (← links)
- Molecular mechanisms of neurodegeneration in Alzheimer's disease (Q33871297) (← links)
- Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease (Q33909959) (← links)
- Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin (Q33959834) (← links)
- A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease (Q33999486) (← links)
- Strategies to delay the onset of Alzheimer's disease. (Q34039304) (← links)
- Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3. (Q34074409) (← links)
- Neuroplasticity and cellular resilience in mood disorders (Q34111006) (← links)
- Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder (Q34146222) (← links)
- New insights into genetic and molecular mechanisms of brain degeneration in tauopathies (Q34156138) (← links)
- Drug development for Alzheimer's disease: where are we now and where are we headed? (Q34166256) (← links)
- Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks (Q34180376) (← links)
- Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment (Q34186921) (← links)
- Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice (Q34195717) (← links)
- Does lithium prevent Alzheimer's disease? (Q34268138) (← links)